Antifungal agents for onychomycoses

被引：18

作者：

Javier Carrillo-Munoz, Alfonso ^{[1
]}

Tur-Tur, Cristina ^{[2
]}

Manuel Hernandez-Molina, Juan ^{[3
]}

Santos, Patricia ^{[4
]}

Cardenes, Delia ^{[1
]}

Giusiano, Gustavo ^{[5
]}

机构：

[1] Assoc Catalana Intel Ligencia Artificial ACIA, Dept Microbiol, Barcelona, Spain

[2] Ctr Atencio Primaria CAP Manso, Serv Diagnost Imatge SDPI, Barcelona, Spain

[3] Hosp Carlos Haya, Microbiol Serv, Malaga, Spain

[4] Hosp Pediat JP Garrahan, Microbiol Serv, Buenos Aires, DF, Argentina

[5] Univ Nacl Nordeste, Inst Med Reg, Dept Micol, Resistencia, Chaco, Argentina

来源：

REVISTA IBEROAMERICANA DE MICOLOGIA | 2010年 / 27卷 / 02期

关键词：

Onychomycosis; Antifungal drugs; Yeasts; Dermatophytes; IN-VITRO ACTIVITY; CICLOPIROX NAIL LACQUER; DERMATOPHYTE TOENAIL ONYCHOMYCOSIS; ORAL TERBINAFINE; COMBINATION THERAPY; TREATMENT OPTIONS; SCOPULARIOPSIS-BREVICAULIS; PHARMACOECONOMIC ANALYSIS; TREAT ONYCHOMYCOSIS; TOPICAL AMOROLFINE;

D O I：

10.1016/j.riam.2010.01.007

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Nail fungal infections are considered one of the major dermatological problems due to their high rate of therapeutic failure, management and treatment difficulties. Long-term treatments, inadequate therapies, mycological misdiagnosis and follow-up, secondary alterations of the nail, and resistant microorganisms, are some of the causes of these complications. Although the discovery of new antifungal agents has provided some effective molecules, none of the current available drugs are totally effective. It is important to continue researching in this field to provide new antifungal agents and combined therapies. (C)09 Revista Ieroamericana de Micologia. Published by Elsevier Espana, S.L. All rights reserved.

引用

页码：49 / 56

页数：8

共 50 条

[31] Pediatric antifungal agents
Cohen-Wolkowiez, Michael
Moran, Cassandra
Benjamin, Daniel K., Jr.
Smith, Phillip B.
CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (06) : 553 - 558
[32] RECENT ANTIFUNGAL AGENTS
DUPONT, B
PATHOLOGIE BIOLOGIE, 1989, 37 (02): : 161 - 162
[33] ANTIFUNGAL AGENTS - REPLY
GUPTA, AK
SAUDER, DN
SHEAR, NH
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (03) : 530 - 531
[34] IMIDAZOLE ANTIFUNGAL AGENTS
BLATCHFORD, NR
JOURNAL OF APPLIED BACTERIOLOGY, 1984, 57 (03): : R5 - R5
[35] ANTIFUNGAL AGENTS IN DERMATOLOGY
LESHER, JL
SMITH, JG
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (03) : 383 - 394
[36] NEW ANTIFUNGAL AGENTS
GRAYBILL, JR
SHARKEYMATHIS, PK
CURRENT OPINION IN INFECTIOUS DISEASES, 1992, 5 (06) : 773 - 780
[37] Sordaricin antifungal agents
Quesnelle, CA
Gill, P
Dodier, M
St Laurent, D
Serrano-Wu, M
Marinier, A
Martel, A
Mazzucco, CE
Stickle, TM
Barrett, JF
Vyas, DM
Balasubramanian, BN
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 519 - 524
[38] Investigational antifungal agents
Ernst, EJ
PHARMACOTHERAPY, 2001, 21 (08): : 165S - 174S
[39] Newer antifungal agents
Larru, Beatriz
Zaoutis, Theoklis E.
CURRENT OPINION IN PEDIATRICS, 2013, 25 (01) : 110 - 115
[40] NEPHROTOXICITY OF ANTIFUNGAL AGENTS
YANG, DJ
RANKIN, GO
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1985, 4 (01) : 37 - 46

← 1 2 3 4 5 →